Annovis Bio Inc (ANVS)
10.07
+0.22
(+2.23%)
USD |
NYSE |
Apr 19, 16:00
10.08
+0.01
(+0.10%)
After-Hours: 19:47
Annovis Bio Total Assets (Quarterly): 10.21M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 10.21M |
September 30, 2023 | 10.22M |
June 30, 2023 | 22.82M |
March 31, 2023 | 25.55M |
December 31, 2022 | 36.02M |
September 30, 2022 | 32.49M |
June 30, 2022 | 36.53M |
March 31, 2022 | 43.30M |
December 31, 2021 | 46.00M |
September 30, 2021 | 47.65M |
June 30, 2021 | 49.50M |
Date | Value |
---|---|
March 31, 2021 | 5.965M |
December 31, 2020 | 8.119M |
September 30, 2020 | 9.402M |
June 30, 2020 | 10.20M |
March 31, 2020 | 11.44M |
December 31, 2019 | 1.117M |
September 30, 2019 | 0.3799M |
June 30, 2019 | 0.3005M |
March 31, 2019 | 0.4313M |
December 31, 2018 | 0.051M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.3005M
Minimum
Jun 2019
49.50M
Maximum
Jun 2021
21.43M
Average
11.44M
Median
Mar 2020
Total Assets (Quarterly) Benchmarks
Abbott Laboratories | 73.21B |
Cerus Corp | 197.75M |
OPKO Health Inc | 2.012B |
Stereotaxis Inc | 41.91M |
PetVivo Holdings Inc | 3.630M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 17.96M |
Shareholders Equity (Quarterly) | -7.751M |